I am designing small proteins (less than 100 amino acids) using in Silico models (Alphafold, Rossetta) for the purpose of developing point-of-care (PoC) diagnostic assays on short timescales. This will allow for faster pre-pandemic diagnosis of emerging diseases when compared to traditional PoCs that rely on antibodies.